SEC Form 4 · accession 0001144204-18-046141
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BFI Co., LLC
10% Owner
Period of report
Aug 21, 2018
Accepted (ET)
Aug 23, 2018 · 9:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Aug 21, 2018 | C | 30,000 | $0.00 | A | 60,000 | D | |
| Class A Common StockF2,F3 | Aug 21, 2018 | S | 10,000 | $50.35 | D | 50,000 | D | |
| Class A Common StockF2,F4 | Aug 22, 2018 | S | 10,000 | $49.92 | D | 40,000 | D | |
| Class A Common StockF2,F5 | Aug 23, 2018 | S | 10,000 | $49.84 | D | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF2,F1 | $0.00 | Aug 21, 2018 | C | 30,000 | D | — | — | Class A Common Stock | 30,000 | 20,216,034 | D |
Explanation of responses
- F1Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.90 to $50.65, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.65, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.70 to $50.10, inclusive.